Which has the lower trailing P/E, HUM or ILMN?

HUM has the lower trailing P/E: HUM trades at 36.78 and ILMN at 50.94. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HUM or ILMN?

Over the past five years, HUM grew revenue faster — HUM at a 12.61% CAGR versus ILMN at 5.04%.

Does HUM or ILMN pay a bigger dividend?

HUM pays a dividend (0.70% yield), while ILMN has no payments in the available dividend history.

Is HUM or ILMN more profitable?

ILMN runs the higher net margin — HUM at 0.88% versus ILMN at 18.36%.

How have HUM and ILMN total returns compared?

Over the past 10 years, HUM delivered 8.85% and ILMN delivered 4.17% annualized total return. Past performance doesn't predict future results.

Humana Inc. (HUM) vs Illumina, Inc. (ILMN)

A side-by-side comparison of Humana Inc. and Illumina, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

HUM

Humana Inc.

$46.63B

$388.36HealthcareDelayed quote: Oct 2, 2026, 4:01 PM EDT

ILMN

Illumina, Inc.

$41.31B

$273.04HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — HUM vs ILMN

growth of $100 · dividends reinvested · last 10y

HUM +134.0% (+8.9%/yr)ILMN +48.2% (+4.0%/yr)HUM compounded faster over this window

HUM ILMN

HUM vs ILMN: by the numbers

•HUM is the larger company ($46.63B vs $41.31B market cap).
•HUM trades at the lower trailing earnings multiple (36.78 vs 50.94 P/E), one valuation lens rather than an overall verdict.
•ILMN converts more revenue to profit (18.36% vs 0.88% net margin).
•HUM grew revenue faster over the past five years (12.61% vs 5.04% CAGR).
•HUM pays a dividend (0.70% yield), while ILMN has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	HUM	ILMN
P/E ratio	36.78	50.94
Forward P/E	42.41	51.00
PEG ratio	N/A	11.99
P/S ratio	0.32	9.19
P/B ratio	2.43	14.56
EV / EBITDA	19.47	35.22
FCF yield	N/A	2.27%

Profitability

Metric	HUM	ILMN
Gross margin	13.65%	66.79%
Operating margin	1.39%	20.97%
Net margin	0.88%	18.36%
ROE	6.65%	29.07%
ROIC	4.52%	13.74%

Dividends

Metric	HUM	ILMN
Dividend yield	0.70%	N/A
Payout ratio	25.14%	N/A

Growth (annualized)

Metric	HUM	ILMN
Revenue CAGR (5Y)	12.61%	5.04%
EPS CAGR (5Y)	-17.27%	4.22%
FCF CAGR (5Y)	N/A	1.03%
Total return CAGR (5Y)	0.35%	-7.09%

Frequently asked

Which has the lower trailing P/E, HUM or ILMN?: HUM has the lower trailing P/E: HUM trades at 36.78 and ILMN at 50.94. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HUM or ILMN?: Over the past five years, HUM grew revenue faster — HUM at a 12.61% CAGR versus ILMN at 5.04%.
Does HUM or ILMN pay a bigger dividend?: HUM pays a dividend (0.70% yield), while ILMN has no payments in the available dividend history.
Is HUM or ILMN more profitable?: ILMN runs the higher net margin — HUM at 0.88% versus ILMN at 18.36%.
How have HUM and ILMN total returns compared?: Over the past 10 years, HUM delivered 8.85% and ILMN delivered 4.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full ILMN analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio Illumina P/E ratio Humana dividend yield Humana ROE Illumina ROE Humana operating margin Illumina operating margin Humana revenue growth Illumina revenue growth Humana free cash flow Illumina free cash flow

Humana & Illumina appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.